From Counts to Insights: A Step-by-Step Workflow for Exploratory Visualization of RNA-seq Data

By Dr. Zubair Khalid, DVM, MS, PhD ·

From Counts to Insights: A Step-by-Step Workflow for Exploratory Visualization of RNA-seq Data

Key Takeaways

  • Exploratory visualization of RNA-seq data bridges raw gene counts and formal differential expression testing, focusing on quality assessment and sample relationship exploration using tools like PCA and heatmaps.
  • The workflow necessitates a validated count matrix, sample metadata with grouping variables, and gene annotation, with Bioconductor packages (DESeq2, edgeR, limma) being central for normalization and variance stabilization.
  • Key visualizations include PCA plots to identify sample clustering and batch effects, sample-to-sample distance heatmaps to assess replicate similarity, and gene-level heatmaps of top variable genes to reveal coherent expression patterns.
  • Volcano plots and MA plots are crucial for visualizing differential expression results, highlighting log2 fold changes against statistical significance (volcano) and mean expression against fold change (MA plot) to identify potential candidates and assess normalization performance.
  • Reproducibility is paramount, requiring documented analysis scripts, session information (R version, package versions), and archived figures in lossless formats, with common troubleshooting involving outlier samples, batch effects, and weak biological signals.
  • The choice of implementation route (R-based workflow, web platforms like iDEP, or automated managers like Snakemake) depends on sample size, reanalysis needs, customization requirements, and available programming expertise.

RNA sequencing produces count matrices that require structured exploration before formal differential expression testing. This workflow covers the complete path from raw gene-level counts to interpretable visual outputs using PCA, heatmaps, volcano plots, and MA plots within the R environment. The target reader is a biology student, researcher, or laboratory professional who has access to a count matrix and needs a reproducible method for quality assessment, sample relationship exploration, and result visualization. The practical outcome is a documented pipeline that transforms tabular count data into publication-ready figures with clear interpretation guidelines and explicit decision criteria for when to proceed or stop.

Scope and Prerequisites for Exploratory RNA-seq Visualization

Exploratory visualization of RNA-seq data sits between two fixed points in the analysis pipeline. The upstream point is the generation of a gene-level count matrix from raw sequencing reads. The downstream point is formal differential expression testing. This workflow assumes the count matrix already exists and contains rows representing genes or transcripts and columns representing individual biological samples. The workflow does not cover read alignment, transcript quantification, or genome assembly, although the quality of those upstream steps directly affects what the exploratory figures will reveal.

The Bioconductor project provides the primary software ecosystem for this workflow, with packages for data import, normalization, exploratory analysis, and differential expression testing [<a href="#ref-1">1</a>]. The workflow described here follows the structure of established end-to-end RNA-seq analysis pipelines that begin with count matrices and proceed through exploratory data analysis before formal testing [<a href="#ref-2">2</a>]. A typical analysis involves pre-processing, exploratory data analysis, differential expression testing, and pathway analysis, with the results informing subsequent experiments and validation studies [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>].

Before starting, confirm that the following inputs are available. The count matrix must contain non-negative integer values representing read or fragment counts per gene per sample. Sample metadata must include at least one grouping variable such as treatment condition, genotype, time point, or tissue type. Gene annotation information, such as gene symbols or Entrez identifiers, must be available for labeling figures. The R environment must have the required packages installed, including ggplot2 for general plotting, pheatmap for heatmap generation, and EnhancedVolcano for volcano plot customization. Additional packages such as DESeq2, edgeR, or limma are needed for normalization and variance stabilization.

The workflow presented here is one of several valid approaches. Alternative tools include web-based platforms such as iDEP, which connects multiple R and Bioconductor packages through an interactive interface and supports exploratory data analysis, differential expression, and pathway analysis for many plant and animal species [<a href="#ref-5">5</a>]. Graphical user interfaces such as inDAGO provide point-and-click access to quality control, read alignment, read summarization, exploratory data analysis, and differential expression identification without requiring programming skills [<a href="#ref-6">6</a>]. Automated workflow managers such as Snakemake can orchestrate the entire pipeline from raw reads through exploratory analysis and differential testing in a modular and reproducible manner [<a href="#ref-7">7</a>]. The choice of tool depends on the user's programming comfort, the scale of the dataset, and the need for reproducibility.

At a Glance: Workflow Components and Decision Points

The table below summarizes the main stages of the exploratory visualization workflow, the primary R packages or functions used at each stage, the key outputs produced, and the decision criteria for moving to the next stage.

Workflow StagePrimary ToolsKey OutputsDecision Criteria to Proceed
Data import and validationread.csv, read.delim, DESeq2, edgeRCount matrix, sample metadata, gene annotationAll sample IDs match between count matrix and metadata, no missing values in critical columns
Quality filtering and normalizationDESeq2, edgeR, limmaFiltered count matrix, normalized counts, variance stabilized dataFiltering removes low-count genes without eliminating known positive control genes
Sample-level quality assessmentggplot2, base R plottingPCA plot, sample-to-sample distance heatmap, clustering dendrogramNo unexpected outliers, biological replicates cluster together, batch effects are visible and attributable
Gene-level pattern explorationpheatmap, ggplot2Heatmap of top variable genes, expression distribution plotsHeatmap shows coherent expression patterns that match experimental design
Differential expression visualizationEnhancedVolcano, ggplot2Volcano plot, MA plotClear separation of significantly changed genes, effect sizes are biologically plausible
Reporting and archivingR Markdown, R script, sessionInfoReproducible script, figure files, session informationAll figures and code are archived with the count matrix and metadata

Data Import and Validation

The first step in the workflow is loading the count matrix and associated metadata into R. The count matrix should be in a tabular format with genes as rows and samples as columns. Common formats include CSV, TSV, or RDS files. The sample metadata should contain one row per sample with columns for sample identifiers and all experimental variables.

Validation checks at this stage prevent downstream errors. Confirm that the sample identifiers in the count matrix columns exactly match the sample identifiers in the metadata rows. Check for duplicate gene identifiers and decide on a strategy for handling them, such as summing counts for duplicated genes or retaining the highest-expressing entry. Verify that all count values are non-negative integers. If the data contains floating point values, investigate whether the counts were already normalized or transformed, because this changes the downstream analysis steps.

The Bioconductor ecosystem provides standardized data structures for RNA-seq analysis. The DESeq2 package uses a DESeqDataSet object that links the count matrix, sample metadata, and experimental design formula [<a href="#ref-2">2</a>]. The edgeR package uses a DGEList object for the same purpose [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. These objects enforce consistency between the count data and the experimental design, reducing the risk of mismatched sample labels during analysis.

For users who prefer not to work directly with R, web-based platforms offer alternative entry points. The iDEP application accepts gene-level count data through an interactive interface and performs exploratory analysis, differential expression, and pathway analysis without requiring local software installation [<a href="#ref-5">5</a>]. The Galaxy Training Network provides accessible tutorials for RNA-seq analysis that cover data import, quality control, and visualization within a web-based environment [<a href="#ref-8">8</a>]. These options are appropriate for users who need to analyze data occasionally or who prefer a graphical interface.

Quality Filtering and Normalization

Raw count matrices contain many genes with zero or very low counts across all samples. These genes provide no information for sample comparison and can distort normalization calculations. Filtering removes genes that are unlikely to be expressed in the experimental system, reducing the number of statistical tests performed later and improving the stability of normalization.

A common filtering approach retains genes with a minimum number of counts in a minimum number of samples. For example, a gene might be retained if it has at least 10 counts in at least 3 samples, but the exact thresholds depend on the sequencing depth and the expected expression levels in the experimental system. The edgeR package provides the filterByExpr function, which automatically determines filtering thresholds based on the library sizes and the experimental design [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. The DESeq2 package performs independent filtering automatically during differential expression testing, but pre-filtering the count matrix before exploratory analysis is still recommended to reduce memory usage and improve plot clarity [<a href="#ref-2">2</a>].

Normalization adjusts for differences in sequencing depth and RNA composition between samples. Without normalization, samples with more total reads appear to have higher expression for all genes, which confounds sample comparisons. The DESeq2 package estimates size factors that account for both sequencing depth and composition effects [<a href="#ref-2">2</a>]. The edgeR package calculates normalization factors using the trimmed mean of M-values method [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. The limma package with the voom method converts count data to log2-counts per million with associated precision weights, enabling linear modeling approaches [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>].

For exploratory visualization, the choice of transformation matters. Raw counts or simple counts per million are not suitable for PCA or heatmap visualization because the variance is dominated by highly expressed genes. The variance stabilizing transformation from DESeq2 and the regularized logarithm transformation from DESeq2 produce data that is approximately homoscedastic, meaning the variance is stable across the range of expression values [<a href="#ref-2">2</a>]. The voom transformation from limma produces log2-counts per million with precision weights that can be used in linear models [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. These transformed values are appropriate inputs for PCA, heatmap, and clustering analyses.

Sample-Level Quality Assessment with PCA

Principal component analysis reduces the high-dimensional gene expression data to a small number of components that capture the largest sources of variation between samples. PCA is the first visualization that reveals whether the experimental design is reflected in the data and whether any samples are problematic.

The PCA plot displays samples as points in a two-dimensional space defined by the first two principal components. Each point represents one sample, and the distance between points reflects the overall similarity of their expression profiles. Samples from the same experimental group should cluster together if the biological signal is strong relative to technical noise. Samples that separate along the first principal component are likely to differ by the largest source of variation in the dataset, which may be the treatment effect, the tissue type, or an unintended batch effect.

Interpretation of PCA plots requires attention to several features. The percentage of variance explained by each principal component is shown in the axis labels. If the first two components explain less than 30 percent of the total variance, the plot may not capture the dominant structure in the data, and additional components should be examined. Samples that fall far from their group cluster may be outliers caused by sample mix-ups, library preparation failures, or contamination. Samples that separate by an unintended variable, such as sequencing batch or processing date, indicate a batch effect that must be addressed before differential expression testing.

The Glimma package provides interactive versions of PCA plots and other exploratory visualizations, allowing users to hover over individual samples to see sample identifiers and metadata [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. This interactivity is useful for identifying outlier samples and for exploring the relationships between samples in datasets with many experimental groups.

Sample-to-Sample Distance Heatmap

The sample-to-sample distance heatmap provides a complementary view to PCA. This visualization computes the Euclidean distance between all pairs of samples based on their transformed expression values and displays the distances as a heatmap with samples arranged by hierarchical clustering.

The distance heatmap reveals the same structure as PCA but in a different format. Samples with similar expression profiles have small distances and cluster together. The dendrogram on the top and side of the heatmap shows the hierarchical relationships between samples. The color scale represents the distance values, with darker colors indicating smaller distances and lighter colors indicating larger distances.

This visualization is particularly useful for detecting sample-level problems that may not be apparent in PCA. A sample that is equidistant from all other samples may have a technical problem that affects its overall expression profile. Two samples that are unexpectedly similar may indicate a sample swap or contamination. The distance heatmap also shows whether biological replicates are more similar to each other than to samples from other conditions, which is the expected pattern for a well-designed experiment.

The pheatmap package provides a straightforward implementation of the sample-to-sample distance heatmap with options for customizing the color scale, the clustering method, and the sample labels [<a href="#ref-1">1</a>]. The base R heatmap function and the heatmap.2 function from the gplots package are alternative options.

Gene-Level Pattern Exploration with Heatmaps

After confirming that the sample-level structure matches the experimental design, the next step is to explore gene-level expression patterns. The most common approach is to select the genes with the highest variance across samples and display their expression values in a heatmap with samples as columns and genes as rows.

The selection of genes for the heatmap is a critical decision. Using all genes produces a heatmap that is dominated by highly expressed genes and is difficult to interpret. A common approach is to select the top 500 to 2000 genes by variance across samples, because these genes are most likely to distinguish the experimental groups. Alternatively, genes can be selected based on their adjusted p-value from a preliminary differential expression analysis, but this approach risks circularity if the same data is used for gene selection and for drawing conclusions about differential expression.

The heatmap should use a diverging color scale, such as blue-white-red or purple-white-yellow, with the center of the scale representing the median expression value across the displayed genes. Row scaling is typically applied so that each gene's expression values are centered and scaled to have a mean of zero and a standard deviation of one. This scaling ensures that genes with different absolute expression levels are comparable in the heatmap.

The pheatmap package provides options for adding annotation bars to the heatmap that display sample metadata, such as treatment group or tissue type [<a href="#ref-1">1</a>]. These annotation bars make it easy to see whether the expression patterns in the heatmap correspond to the experimental design. The ComplexHeatmap package provides more advanced options for heatmap customization, including split heatmaps and complex annotation layouts.

Interpretation of the gene-level heatmap focuses on whether the expression patterns form coherent blocks that correspond to experimental groups. Genes that are upregulated in one condition and downregulated in another should form visible blocks of consistent color. The hierarchical clustering of genes on the left side of the heatmap groups genes with similar expression patterns, which may correspond to shared biological functions or regulatory mechanisms.

Differential Expression Visualization with Volcano Plots

Volcano plots display the results of differential expression analysis in a single figure that shows both the magnitude of change and the statistical significance for every gene. The x-axis represents the log2 fold change between conditions, and the y-axis represents the negative log10 of the adjusted p-value. Genes with large fold changes and small p-values appear in the upper left and upper right corners of the plot.

The volcano plot is generated after differential expression testing has been performed, but it serves an exploratory purpose by revealing the overall distribution of effects. The plot shows how many genes are significantly changed, whether the changes are symmetric between upregulation and downregulation, and whether there are genes with large fold changes that do not reach statistical significance.

The EnhancedVolcano package provides a customizable implementation of the volcano plot with options for labeling the most significant genes, adjusting the threshold lines, and controlling the color scheme [<a href="#ref-1">1</a>]. The standard ggplot2 package can also be used to create volcano plots with full control over the appearance.

Threshold selection for the volcano plot should follow the conventions of the differential expression analysis. A common threshold is an adjusted p-value below 0.05 and an absolute log2 fold change of at least 1, corresponding to a 2-fold change in expression [<a href="#ref-9">9</a>]. However, the appropriate thresholds depend on the experimental system and the goals of the analysis. Exploratory analyses may use more lenient thresholds, such as an unadjusted p-value below 0.05 and an absolute fold change of 1.5, to generate hypotheses for validation [<a href="#ref-10">10</a>].

The interpretation of volcano plots should consider the distribution of points. A well-behaved analysis produces a cloud of points that is roughly symmetric around zero on the x-axis, with significant genes extending upward from the cloud. An asymmetric distribution may indicate a problem with the normalization or a genuine biological effect that predominantly affects one direction of change. Genes with very large fold changes but non-significant p-values may have high variance between replicates, and these genes may be worth examining individually.

Differential Expression Visualization with MA Plots

The MA plot displays the relationship between the average expression level of each gene and its log2 fold change between conditions. The x-axis represents the mean of the normalized counts across all samples, and the y-axis represents the log2 fold change. The name MA comes from the plot's axes: M for minus, representing the log ratio, and A for average, representing the mean expression.

The MA plot serves a different purpose from the volcano plot. The volcano plot emphasizes statistical significance, while the MA plot emphasizes the relationship between expression level and effect size. In most RNA-seq experiments, genes with low expression levels show more variable fold changes than genes with high expression levels. The MA plot makes this relationship visible and allows the analyst to check whether the differential expression analysis has appropriately accounted for this mean-variance relationship.

The DESeq2 package provides the plotMA function, which displays the MA plot with significant genes highlighted in a distinct color [<a href="#ref-2">2</a>]. The limma package provides a similar function for MA plots of voom-transformed data [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. The ggplot2 package can be used to create custom MA plots with additional features such as gene labels and smoothed trend lines.

Interpretation of the MA plot focuses on the shape of the point cloud. The majority of genes should have log2 fold changes near zero, with the spread of points increasing at low expression levels. Significant genes should be distributed across the range of expression levels, although there is often a concentration of significant genes at moderate to high expression levels where the statistical power is greatest. A systematic shift of the point cloud away from zero may indicate a normalization problem or a global change in expression between conditions.

Practical Implementation Steps

The following steps provide a concrete implementation path for the workflow described above. These steps assume a working R installation with the required packages available from Bioconductor [<a href="#ref-1">1</a>].

Step 1: Load the count matrix and metadata into R. Use read.csv or read.delim for tabular data files. Verify that the sample identifiers match between the count matrix and the metadata.

Step 2: Create the appropriate data object for the chosen analysis package. For DESeq2, create a DESeqDataSet object using the DESeqDataSetFromMatrix function. For edgeR, create a DGEList object using the DGEList function.

Step 3: Filter low-count genes. Use the filterByExpr function from edgeR or manual filtering based on count thresholds. Record the number of genes retained after filtering.

Step 4: Calculate normalization factors and transformed values. For DESeq2, use the estimateSizeFactors function followed by the vst or rlog function. For edgeR, use the calcNormFactors function followed by the cpm function with log transformation.

Step 5: Generate the PCA plot using the plotPCA function from DESeq2 or a custom ggplot2 implementation. Examine the plot for sample clustering and outliers.

Step 6: Generate the sample-to-sample distance heatmap using the pheatmap package. Compare the clustering pattern with the experimental design.

Step 7: Select the top variable genes and generate the gene-level heatmap using the pheatmap package with sample annotation bars.

Step 8: Perform differential expression analysis using DESeq2, edgeR with limma voom, or another appropriate method. Generate the volcano plot using EnhancedVolcano and the MA plot using the plotMA function or a custom ggplot2 implementation.

Step 9: Save all figures as high-resolution image files and save the R script with the complete analysis code. Record the session information using the sessionInfo function for reproducibility.

Records and Measurements

Documentation of the exploratory analysis is essential for reproducibility and for the interpretation of downstream results. The following records should be maintained for each analysis.

The analysis script should contain all code used to generate the figures, including the package versions and the exact parameters used for filtering, normalization, and visualization. The script should be saved with the count matrix and metadata in a single project directory.

The session information should be recorded using the sessionInfo function, which lists the R version, the platform, and the versions of all attached packages. This information is critical for reproducing the analysis at a later time, because package updates can change the results of the analysis.

The filtering and normalization decisions should be recorded, including the number of genes retained after filtering, the normalization method used, and the transformation applied. These decisions affect the interpretation of the exploratory figures and should be reported in any publication or thesis that uses the analysis.

The exploratory figures should be saved in a lossless format such as PDF or PNG with sufficient resolution for publication. The figures should be named according to their content, such as PCA_plot.pdf, sample_distance_heatmap.pdf, and volcano_plot.pdf.

Common Failure Patterns and Troubleshooting

Several recurring problems appear during exploratory visualization of RNA-seq data. Recognizing these patterns helps the analyst identify the underlying cause and take corrective action.

The first common failure is the appearance of a single outlier sample that separates from all other samples in the PCA plot. This pattern may indicate a sample mix-up, a library preparation failure, or contamination. The analyst should check the sample identifiers, review the quality control metrics for the sequencing run, and consider whether the outlier should be excluded from further analysis. If the outlier is excluded, the decision must be documented and justified.

The second common failure is the separation of samples by an unintended variable instead of by the experimental condition. This pattern indicates a batch effect, which may be caused by differences in sequencing runs, library preparation batches, or sample processing dates. The analyst should examine the sample metadata for potential batch variables and consider whether batch correction is needed before differential expression testing.

The third common failure is the absence of any clear structure in the PCA plot, with samples scattered without grouping by experimental condition. This pattern may indicate that the biological signal is weak relative to technical noise, that the normalization was inappropriate, or that the experimental design has insufficient power. The analyst should check the sequencing depth, the number of biological replicates, and the variance explained by the principal components.

The fourth common failure is the presence of genes with extreme fold changes that are not statistically significant in the volcano plot. This pattern may indicate high variance between replicates for those genes, which can be caused by dropout effects, low expression levels, or technical artifacts. The analyst should examine the raw counts for these genes to determine whether the variation is biologically meaningful or technical in origin.

The fifth common failure is a heatmap that shows no coherent blocks of expression corresponding to experimental groups. This pattern may indicate that the selected genes do not distinguish the conditions, that the normalization was inappropriate, or that the experimental effect is limited to a small number of genes. The analyst should try different gene selection criteria and examine the expression of known marker genes for the experimental system.

Limitations and Interpretation Boundaries

Exploratory visualization provides descriptive information about the structure of the data, but it does not provide statistical evidence for differential expression. The patterns observed in PCA plots, heatmaps, and volcano plots are suggestive and require confirmation through formal statistical testing.

The choice of visualization parameters can influence the appearance of the figures. The number of genes selected for the heatmap, the transformation applied to the counts, and the thresholds used in the volcano plot all affect what is visible in the figures. These choices should be made before examining the results to avoid confirmation bias, and they should be reported alongside the figures.

The exploratory figures are based on the quality of the upstream analysis. Errors in read alignment, transcript quantification, or gene annotation will propagate into the count matrix and affect the exploratory visualizations. The analyst should verify the quality of the upstream steps before interpreting the exploratory figures.

The interpretation of exploratory figures requires biological context. A PCA plot that shows separation between conditions is only meaningful if the conditions are expected to differ in their transcriptomes. A heatmap that shows coherent expression patterns is only interpretable if the analyst knows the biology of the experimental system. The exploratory analysis should be guided by biological questions, not performed in isolation.

The sample sizes in RNA-seq experiments are often small, particularly for exploratory studies. The patterns observed in PCA plots and heatmaps may be driven by a small number of influential samples or genes. The analyst should examine the robustness of the observed patterns by repeating the analysis with different parameters and by examining the contribution of individual samples and genes to the overall structure.

Reproducibility and Reporting Standards

Reproducibility is a central requirement for RNA-seq analysis. The exploratory visualization workflow should be documented in a way that allows another researcher to repeat the analysis and obtain the same figures.

The analysis script should be organized into sections that correspond to the workflow stages, with comments explaining the purpose of each step. The script should use relative file paths so that it can be run on a different computer without modification. The script should include the session information at the end to record the package versions.

The nf-core community provides standards for reproducible bioinformatics workflows, including guidelines for pipeline structure, documentation, and containerization [<a href="#ref-11">11</a>]. While the exploratory visualization workflow described here is simpler than a full nf-core pipeline, the principles of modularity, documentation, and version control apply equally.

The Carpentries provides training in the foundational computing skills needed for reproducible analysis, including the shell, Git for version control, and programming in R or Python [<a href="#ref-12">12</a>]. Researchers who are new to computational analysis should consider completing this training before undertaking RNA-seq analysis.

The EMBL-EBI Training program offers courses and materials on bioinformatics data resources and analysis methods, including RNA-seq analysis [<a href="#ref-13">13</a>]. These resources provide context for the tools and approaches used in the exploratory visualization workflow.

The NCBI provides access to the primary sequence databases and analysis tools that support RNA-seq research, including the Sequence Read Archive for raw sequencing data and the Gene Expression Omnibus for processed expression data [<a href="#ref-14">14</a>]. These resources are essential for researchers who need to access public datasets for exploratory analysis or validation.

Professional Escalation Criteria

The exploratory visualization workflow may reveal problems that require consultation with a bioinformatics specialist or a statistician. The following situations warrant escalation.

If the PCA plot shows a clear batch effect that cannot be attributed to a known experimental variable, consult a bioinformatics specialist about batch correction methods. Applying an inappropriate batch correction can introduce artifacts that invalidate the downstream analysis.

If the sample-to-sample distance heatmap shows that biological replicates are less similar to each other than to samples from other conditions, consult a statistician about the experimental design. The experiment may have insufficient power to detect the biological effect of interest.

If the volcano plot shows an unusual distribution of p-values, such as a large number of genes with p-values near zero or a bimodal distribution, consult a statistician about the appropriateness of the statistical model. The model assumptions may be violated, or the data may contain artifacts that require special handling.

If the MA plot shows a systematic shift of the point cloud away from zero, consult a bioinformatics specialist about the normalization. The normalization may be inappropriate for the data, or the experimental design may require a more complex normalization approach.

If the exploratory analysis is part of a regulated study or a clinical investigation, consult the appropriate regulatory or institutional review body before proceeding. The analysis may be subject to specific reporting requirements or validation standards.

Decision Framework for Choosing Between Visualization Tools and Workflow Platforms

The exploratory visualization workflow described above can be implemented through several distinct tool combinations, and the choice between them affects the time required, the reproducibility of the analysis, and the depth of interpretation possible. This section provides a practical decision framework for selecting between the R-based workflow, web-based platforms, and automated workflow managers, along with criteria for when to switch between approaches during a project.

Comparing Implementation Routes

The R-based workflow using DESeq2, edgeR, limma, ggplot2, pheatmap, and EnhancedVolcano offers the greatest flexibility for customizing figures and integrating with downstream statistical analysis. This approach requires programming proficiency but produces a complete record of every analysis decision in the form of an executable script. The Bioconductor project maintains the packages used in this workflow and provides documentation for installation and usage [<a href="#ref-1">1</a>]. The workflow structure follows established end-to-end RNA-seq analysis pipelines that begin with count matrices and proceed through exploratory data analysis before formal testing [<a href="#ref-2">2</a>][<a href="#ref-15">15</a>].

Web-based platforms provide an alternative route for researchers who do not program regularly. The iDEP application connects multiple R and Bioconductor packages through an interactive interface and supports exploratory data analysis, differential expression, and pathway analysis for many plant and animal species [<a href="#ref-5">5</a>]. The inDAGO interface provides point-and-click access to quality control, read alignment, read summarization, exploratory data analysis, and differential expression identification, and it can perform complete analyses on a standard laptop with 16 GB of RAM without requiring high-performance computing [<a href="#ref-6">6</a>]. These platforms lower the technical barrier to entry but may limit the customization of figures and the integration of novel analysis steps.

Automated workflow managers such as Snakemake orchestrate the entire pipeline from raw reads through exploratory analysis and differential testing in a modular and reproducible manner [<a href="#ref-7">7</a>]. The nf-core community provides standards for reproducible bioinformatics workflows, including guidelines for pipeline structure, documentation, and containerization [<a href="#ref-11">11</a>]. These approaches are appropriate for large projects, multi-sample studies, or analyses that must be repeated as new data become available.

Selection Criteria Based on Project Characteristics

The choice between implementation routes should be guided by four project characteristics: the number of samples, the frequency of reanalysis, the need for custom visualization, and the programming skills available in the research group.

For projects with fewer than 20 samples that will be analyzed once, the R-based workflow or a web-based platform both work well. The R-based workflow provides a permanent script that can be revisited if reviewers request additional figures. Web-based platforms such as iDEP generate downloadable R code that reproduces the analysis, which partially addresses the reproducibility concern [<a href="#ref-5">5</a>].

For projects with more than 50 samples or with multiple experimental factors, the R-based workflow is preferred because it allows systematic exploration of batch effects and interactions through customized PCA plots and heatmaps. Automated workflow managers become valuable when the analysis must be repeated for multiple datasets or when the pipeline must be shared across a research group [<a href="#ref-7">7</a>].

For projects that require publication-quality figures with specific formatting, the R-based workflow with ggplot2 and pheatmap provides the most control over every visual element. Web-based platforms generate standard plots that may not match journal requirements without additional editing.

For research groups with limited programming experience, starting with a web-based platform such as iDEP or inDAGO allows the group to complete an initial exploration of the data while building familiarity with the underlying analysis steps [<a href="#ref-6">6</a>][<a href="#ref-5">5</a>]. The Galaxy Training Network provides accessible tutorials for RNA-seq analysis that cover data import, quality control, and visualization within a web-based environment [<a href="#ref-8">8</a>]. As the group gains experience, they can transition to the R-based workflow for greater flexibility.

Switching Between Approaches During a Project

A common pattern is to begin with a web-based platform for initial data exploration and then switch to the R-based workflow for the final analysis. This approach works well when the initial exploration identifies the key questions and the R-based workflow is used to produce the final figures and statistical results. The iDEP application supports this transition by allowing users to download the R code that reproduces the analysis [<a href="#ref-5">5</a>].

The reverse transition, from R to a web-based platform, is less common but may be useful for sharing results with collaborators who do not use R. The Glimma package provides interactive versions of PCA plots and other exploratory visualizations that can be shared as HTML files, allowing collaborators to explore the data without installing R packages [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>].

Documentation Requirements for Each Approach

The documentation requirements differ by implementation route. The R-based workflow requires a complete script with session information recorded using the sessionInfo function. The script should be saved with the count matrix and metadata in a single project directory, and all filtering and normalization decisions should be recorded.

Web-based platforms require documentation of the platform version, the input file formats, and the parameters selected in the interface. The iDEP application generates downloadable R code that serves as the analysis record [<a href="#ref-5">5</a>]. The inDAGO interface generates intermediate outputs and publication-ready plots while guiding users through each analysis step [<a href="#ref-6">6</a>].

Automated workflow managers require documentation of the pipeline version, the configuration file, and the container images used. The nf-core documentation provides standards for pipeline structure and configuration that support reproducibility [<a href="#ref-11">11</a>].

Cost and Resource Considerations

The R-based workflow and web-based platforms differ in their computational requirements. The R-based workflow runs locally and requires a computer with sufficient memory to hold the count matrix and perform the normalization calculations. Most modern laptops with 8 to 16 GB of RAM can handle gene-level count matrices from bulk RNA-seq experiments. The inDAGO platform explicitly supports analysis on standard laptops with 16 GB of RAM [<a href="#ref-6">6</a>].

Web-based platforms shift the computational burden to remote servers. This approach is useful when the local computer lacks the memory or processing power for the analysis, but it requires a stable internet connection and may involve upload time for large count matrices.

Automated workflow managers can run on local computers, institutional clusters, or cloud infrastructure. The modular design allows the same pipeline to scale from a laptop to a high-performance computing environment without changing the analysis code [<a href="#ref-7">7</a>].

Decision Checklist for Tool Selection

Use the following checklist to select the implementation route for a specific project. Answer each question and choose the route that satisfies the most criteria.

Confirm that the count matrix is in gene-level format with non-negative integer values. If the data are at transcript level or contain floating point values, additional processing is needed before any visualization workflow can begin.

Determine whether the analysis will be performed once or repeated. A single analysis can use any route. Repeated analyses favor the R-based workflow or an automated workflow manager because the script or pipeline can be rerun with minimal modification.

Determine whether custom figure formatting is required. Publication-ready figures with specific journal formatting favor the R-based workflow with ggplot2 and pheatmap.

Assess the programming skills available in the research group. Groups without regular R users should start with a web-based platform and transition to R as skills develop.

Determine whether the analysis must be shared with collaborators. Interactive visualizations from the Glimma package or web-based platforms facilitate sharing with non-programmers [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>].

Check whether the project involves multiple datasets or repeated analyses. Automated workflow managers provide the strongest reproducibility guarantees for these scenarios [<a href="#ref-7">7</a>].

Escalation Criteria for Tool Limitations

If the selected tool cannot produce the required visualization or analysis, escalate to a more flexible approach. A web-based platform that cannot generate a specific figure should be supplemented with the R-based workflow for that figure. An R-based workflow that cannot handle the dataset size should be moved to an automated workflow manager that can run on high-performance computing infrastructure.

If the analysis reveals unexpected patterns that require additional statistical methods, such as batch correction or surrogate variable analysis, escalate to the R-based workflow where these methods are available through Bioconductor packages [<a href="#ref-1">1</a>]. Web-based platforms may not expose these advanced methods.

If the project becomes part of a regulated study or clinical investigation, consult the appropriate regulatory or institutional review body before selecting the analysis tools. The analysis may be subject to specific reporting requirements or validation standards that favor particular implementation routes.

Frequently Asked Questions

What is the difference between exploratory visualization and formal differential expression analysis?

Exploratory visualization describes the structure of the data without making statistical claims about individual genes. PCA plots, heatmaps, and sample distance matrices reveal how samples relate to each other and whether the experimental design is reflected in the data. Formal differential expression analysis uses statistical models to test whether individual genes are significantly changed between conditions, producing adjusted p-values and log2 fold changes for every gene. The exploratory analysis is performed before the formal analysis to check data quality and to generate hypotheses, while the formal analysis provides the statistical evidence for differential expression.

Which R packages are needed for this workflow?

The core packages are ggplot2 for general plotting, pheatmap for heatmap generation, and EnhancedVolcano for volcano plot customization. The analysis packages include DESeq2, edgeR, and limma for normalization and differential expression testing. All of these packages are available from the Bioconductor project [<a href="#ref-1">1</a>]. The Glimma package provides interactive versions of the exploratory plots [<a href="#ref-3">3</a>][<a href="#ref-4">4</a>]. Additional packages may be needed for data import and manipulation, such as readr and dplyr from the tidyverse.

How many biological replicates are needed for meaningful exploratory visualization?

The number of biological replicates needed depends on the biological variability of the experimental system and the magnitude of the expected effect. A minimum of three biological replicates per condition is commonly recommended for differential expression analysis, and the same guidance applies to exploratory visualization. With fewer replicates, the PCA plot may not show clear clustering, and the heatmap may be dominated by noise. With more replicates, the patterns become more stable and the confidence in the observed structure increases.

What should I do if the PCA plot shows an outlier sample?

First, verify that the sample identifier in the count matrix matches the correct sample in the metadata. Check the quality control metrics for the sequencing run, including the total read count, the alignment rate, and the gene detection rate. Examine whether the outlier is also visible in the sample-to-sample distance heatmap. If the outlier appears to be a technical failure, consider excluding it from the analysis and document the exclusion. If the outlier appears to be biologically meaningful, investigate the sample history and consider whether it represents a distinct biological state.

Can I use this workflow with data from public repositories?

Yes, the workflow accepts count matrices from any source, including public repositories such as the NCBI Gene Expression Omnibus [<a href="#ref-14">14</a>]. Public datasets provide a cost-effective starting point for exploratory biomarker discovery, and modular analysis pipelines can combine multiple public datasets to increase statistical power [<a href="#ref-16">16</a>]. When using public data, verify the experimental design, the sample metadata, and the data processing steps before applying the workflow.

What is the role of normalization in exploratory visualization?

Normalization adjusts for differences in sequencing depth and RNA composition between samples, making the expression values comparable across samples. Without normalization, samples with more total reads appear to have higher expression for all genes, which confounds the PCA plot and the heatmap. The choice of normalization method affects the exploratory figures, so the method should be appropriate for the data and should be reported with the analysis.

How do I choose the genes for the heatmap?

The most common approach is to select the genes with the highest variance across samples, typically the top 500 to 2000 genes. These genes are most likely to distinguish the experimental groups. Alternatively, genes can be selected based on their expression level, their biological relevance, or their membership in known pathways. The choice of gene selection method affects the appearance of the heatmap, so the method should be reported with the figure.

What should I report when publishing the exploratory analysis?

Report the software versions, the filtering criteria, the normalization method, the transformation applied, and the parameters used for each figure. Include the session information from R to document the exact package versions. Provide the analysis script and the count matrix as supplementary data so that other researchers can reproduce the figures. Describe the interpretation of each figure in the results section, including any samples that were excluded and the reasons for exclusion.

Related Bioinformatics Guides

Related Clinical & Scientific Guides

References and Further Reading

[1] [Bioconductor](https://bioconductor.org/). Bioconductor Project. [2] [RNA-Seq workflow: gene-level exploratory analysis and differential expression.](https://pubmed.ncbi.nlm.nih.gov/26674615). F1000Research, 2015. [3] [RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR.](https://pubmed.ncbi.nlm.nih.gov/27441086). F1000Research, 2016. [4] [RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR](https://doi.org/10.12688/f1000research.9005.2). F1000Research, 2016. [5] [iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data.](https://pubmed.ncbi.nlm.nih.gov/30567491). BMC bioinformatics, 2018. [6] [inDAGO: a user-friendly interface for seamless dual and bulk RNA-Seq analysis.](https://pubmed.ncbi.nlm.nih.gov/41355892). Frontiers in bioinformatics, 2025. [7] [ARMOR: An Automated Reproducible MOdular Workflow for Preprocessing and Differential Analysis of RNA-seq Data.](https://pubmed.ncbi.nlm.nih.gov/31088905). G3 (Bethesda, Md.), 2019. [8] [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project. [9] [An End-to-End Reproducible RNA-Seq Workflow from Raw Sequencing Reads to Differential Expression, Pathway Enrichment, and Biological Interpretation](https://doi.org/10.21203/rs.3.rs-10682168/v1). 2026. [10] [Exploratory transcriptomic analysis suggests candidate genes associated with loss of response to ustekinumab in Crohn's disease.](https://doi.org/10.3389/fgene.2026.1812181). 2026. [11] [nf-core Documentation](https://nf-co.re/docs). nf-core. [12] [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries. [13] [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute. [14] [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information. [15] [RNA-Seq workflow: Gene-level exploratory analysis and differential expression](https://doi.org/10.12688/f1000research.7035.2). F1000research, 2016. [16] [Modular RNA-seq Analytics for Exploratory Biomarker Discovery using Public Data.](https://doi.org/10.1016/j.jmoldx.2026.07.005). Journal of Molecular Diagnostics, 2026.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.